Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
CRISPR Craze to Transform Cardiac Biology: Trends in Molecular Medicine
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening | Nature Protocols
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM
Controlling and enhancing CRISPR systems | Nature Chemical Biology
In utero CRISPR-mediated therapeutic editing of metabolic genes | Nature Medicine
Nature Medicine on Twitter: "In a first-in-human phase I #clinicaltrial in patients with #lungcancer, infusions of autologous T cells with CRISPR-Cas9 edited PD-1 gene were well-tolerated and did not lead to severe
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
Nature Collections: CRISPR-Cas9 Genome Editing - Scientific American
The kill-switch for CRISPR that could make gene-editing safer
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Frontiers | Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9 | Plant Science
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Nature Medicine
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR gene editing - Wikipedia
/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Landmark CRISPR trial shows promise against deadly disease
Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer: Trends in Molecular Medicine
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer | Nature Medicine
CRISPR-engineered T cells in patients with refractory cancer
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 | Nature Immunology
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
The Dark Side of CRISPR - Scientific American
Developing CRISPR/CAS9 technologies for research and medicine - MedCrave online
CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)
